Skip to content

Clinical trials

Observational Hepatitis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Observational Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20101
20181
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The First Hospital of Jilin University2
Beijing Municipal Administration of Hospitals1
Nanfang Hospital, Southern Medical University1
Novartis Pharmaceuticals1
Peking University1
Wuxi Hisky Medical Technology Co Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis7
Fatty Liver2
Hepatitis B2
Hepatitis C2
Liver Cirrhosis2
Non-alcoholic Fatty Liver Disease2
DNA Virus Infections1
Digestive System Diseases1
Hematologic Diseases1
Hepatitis B, Chronic1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.